5-HO-DPT


5-HO-DPT, also known as 5-hydroxy-N,''N-dipropyltryptamine, as well as N'',N-dipropylserotonin, is a serotonin receptor modulator of the tryptamine and 5-hydroxytryptamine families. It is the N,''N''-dipropyl derivative of serotonin.

Pharmacology

Pharmacodynamics

The drug shows affinity for the serotonin 5-HT1A receptor, the serotonin 5-HT1B receptor, and the serotonin 5-HT2 receptor. 5-HO-DPT was not tested itself, but its O-methyl ether 5-MeO-DPT fully substituted for the psychedelic drug DOM in rodent drug discrimination tests and partially substituted for 8-OH-DPAT in these tests followed by behavioral disruption at higher doses.
5-Hydroxytryptamines like bufotenin are known to be hydrophilic and peripherally selective, in turn resulting in difficulty crossing the blood–brain barrier and exerting central effects. However, 5-HO-DPT is notable in having much greater lipophilicity in comparison to bufotenin owing to its propyl groups.

Chemistry

Analogues

s of 5-HO-DPT include dipropyltryptamine, 4-HO-DPT, 4-AcO-DPT, 5-MeO-DPT, bufotenin, 5-HO-MET, 5-HO-DET, and 5-HO-DiPT, among others.

History

5-HO-DPT was first described in the scientific literature by Richard Glennon and colleagues by 1988.